This paper reports the results of a population study designed to assess the standards of epilepsy care within a geographical population in relation to diagnosis, seizure management and quality of life. One of the findings was the unexpectedly high frequency of the misdiagnosis of epilepsy. Forty-nine of 214 patients with a primary diagnosis of epilepsy were subsequently found to have been misdiagnosed following a specialist review and investigations. All except two have been withdrawn from antiepileptic medication. The diagnosis of epilepsy was disputed in a further 26 patients. Of the 49 patients, 20 were found to have cardiovascular or cerebrovascular pathology. Seven had only ever experienced a single seizure and a further 10 were found to have underlying psychopathology. Such observations support the view that epilepsy is frequently misdiagnosed and this paper discusses some of the implications of misdiagnosis.
INTRODUCTION
The diagnosis of epilepsy is essentially a clinical one and often complicated because of the variety of events which can resemble an epileptic seizure'y2. It has been estimated that approximately 20% of patients attending specialist epilepsy clinics do not have epilepsy3.
This paper reports the results of a population study assessing the prevalence of epilepsy within a community and the burden of care for this condition. One of the findings was the unexpectedly high frequency of the misdiagnosis of epilepsy.
MATERIALS AND METHODS
In 1995 the CARE project was launched by The David Lewis Centre in partnership with a group of general practices, and with the support of the Department of Health. CARE stands for Community Awareness and Resources for Epilepsy.
The purpose of the project was to audit the standards of epilepsy care within a geographical population in relation to diagnosis, seizure management and quality of life. A new specialist epilepsy service was then initiated and the population surveyed after a year to *The CARE Project has been sponsored by the Department of Health, and supported by educational grants from Glaxo Wellcome, Parke Davis and Sanofi Winthrop.
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+ 04 $12.00/O identify any health gains (or otherwise) and impact on the burden of care. The project currently includes seven general practices ranging from a single-handed nonfundholding practice to a large total-purchasing fundholding consortium. The practices involved in the project provided the names of all registered patients who had a diagnostic code for epilepsy. This sample was then crossreferenced against prescription information and discussions with the general practitioners. The sample was restricted to patients aged 5 years and over because of the frequently complicated nature of seizures and the underlying cerebral condition in very young children.
All patients were initially informed by their practitioner of the new clinic to be held in the health centre. Following this initial postal contact, all patients were then invited for a specialist consultation. The clinic was run by a consultant neuropsychiatrist and an epilepsy specialist nurse. If appropriate, electro-encephalography (EEG) was carried out in the clinic. Other investigations such as Magnetic Resonance Imaging (MRI) or head-up tilting were carried out in the nearby teaching hospital.
The diagnosis of epilepsy was made by a consultant and experienced epileptologist. The diagnosis was based on clinical history, including response to medication, seizure description and results of EEG investigations, including videotelemetry and ambulatory monitoring. Where an alternative diagnosis was suspected, further investigations and referrals to other consultants were arranged. All patients were involved in the decision regarding further investigation and management, with the principle of patient empowerment and choice a cornerstone of the specialist service*.
RESULTS
In a population of approximately 40 000 registered patients, 261 were identified as having a primary diagnosis of epilepsy and invited for review. This represents a prevalence of epilepsy of 0.65%. A number of patients identified by the practice had died or moved outside the catchment area and a few patients contacted the practices to decline any review.
Forty-seven patients failed to attend (18%) although over time, a significant number have subsequently requested an appointment and been seen, although they are not yet included in this sample.
Of the patients seen in the clinic, 49 (23.2%) were identified as not having epilepsy and all but two have since been withdrawn from antiepileptic medication. Of the two patients still taking antiepileptic drugs (AEDs), one remains on a small subtherapeutic dose, as she is unhappy to withdraw all medication after 40 years on treatment, and the other is still in the process of drug withdrawal. Only patients who showed evidence of an alternative diagnosis, with no evidence to support the diagnosis of epilepsy and who were withdrawn from medication (other than the two cases mentioned) were considered to be cases of misdiagnosis. Table 1 gives a breakdown of the new diagnoses made. The significant points to draw from this table are that 20 of the 49 patients (9.3%) were found to have a cardiovascular or cerebrovascular condition, including: transient ischaemic episodes; vertebrobasilar insufficiency; postural hypotension; congenital heart disease; carotid sinus syndrome; sinus node disease and vasovagal syncope. Two patients have since become seizure-free following the insertion of a cardiac pacemaker and one is awaiting coronary angioplasty.
Ten patients (4.7%) were found to have underlying psychopathology. The diagnoses included depression, generalized anxiety disorder, panic disorder and obsessional compulsive disorder. Of this group, three were more extensively investigated and diagnosed as having non-epileptic attack disorder, with hysterical or dissociative disorder, factitious disorder and somatization disorder as the underlying aetiologies.
Seven patients (3.3%) had only ever experienced a single seizure and by definition these patients do not suffer from epilepsy, since they have not experienced a 'recurrent' seizure disorder. Two of these seven patients suffered a single seizure following cerebrovascular accidents; the provoking factor in the other five patients included head injury, pre-eclampsia and following a general anaesthetic.
In a further 26 cases, the diagnosis of epilepsy was disputed but for various reasons they have not yet been included. In some patients, further investigations are necessary, whilst others have decided to remain on a therapeutic dose of medication. Some patients in this group could possibly have both epilepsy and other nonepileptic seizures.
In the 12 months prior to the new diagnosis being made, from the sample of 49 patients, nine required A&E attendance; four required hospital admission and the GP was called out after hours on one occasion. Ten patients had seen a specialist in the previous 12 months for their epilepsy, for a total of 17 visits. Nineteen of the 49 patients were on AEDs, including one on two drugs and one on three. Eleven of the 19 patients were on either phenytoin, phenobarbitone, or both, without regular monitoring or serum levels.
DISCUSSION
Many definitions of epilepsy exist but most would include the criteria that seizures are: spontaneous or unprovoked, recurrent (two or more), abnormal and excessive discharges of electrochemical activity in the brain resulting in clinical manifestations4. All of these criteria are considered essential to the diagnosis. Epilepsy cannot be diagnosed therefore on the basis of a single seizure since it is a recurrent seizure disorder. Similarly, drug or alcohol withdrawal seizures, seizures which occur during coma or following a head injury, or any other 'non-spontaneous' or provoked seizure, cannot be regarded as epilepsy.
There are multiple causes of seizures and although epilepsy remains the most common, there appears to be little appreciation or understanding among clinicians of other potentially life-threatening conditions which can present with seizures. It is sobering for example, to note the l-year mortality rates for people with syncope, a phenomenon often mistakenly diagnosed as epilepsy. It is reported that where a cardiac cause for syncope is found, the l-year mortality rate is between 18% and 33%5-9 compared with 3-6% for syncope of unknown origin"8. A significant number of patients are placed on antiepileptic medication, which may exacerbate the underlying condition or lead to debilitating side-effects. Moreover, they frequently spend many years struggling with the psychosocial implications of the diagnosis of epilepsy. It is also not uncommon to find patients on large doses of AEDs whilst no prophylaxis or preventative measures are taken to address the underlying condition. For example, patients who experience seizures following a cerebral ischaemic event are placed on AEDs whilst their blood pressure is not adequately controlled and they have not considered taking non-steroidal drugs.
Although hypoxia and head injuries during seizures can cause cerebral damage, there is little evidence that the seizure itself leads to a worsening of cerebral function in the vast majority of cases. The underlying condition on the other hand, can occasionally be life-threatening, yet many clinicians appear to take the view that seizure control is of primary importance. The management of seizures is relatively simple if this is the therapeutic goal. Modified narcosis is, however, inappropriate in the majority of cases. The correct diagnosis and appropriate management of the underlying condition giving rise to the seizure disorder, ought to be the primary therapeutic objective. The management of epilepsy also includes counselling and empowerment of the patient, enabling them to identify and manage or avoid factors which precipitate seizures*.
In order to make an accurate diagnosis of epilepsy, sleep-deprived EEGs and ambulatory monitoring are useful tools, although not widely available or extensively used. These investigations are particularly important where diagnostic doubts continue or the patient remains refractory to treatment. Nevertheless, the diagnosis of epilepsy remains a clinical one, which is why the precise and detailed description of what occurs peri-ictally is essential and the experience and knowledge of the clinician remains the most important factor in determining diagnostic accuracy.
It is significant that of the patients seen, possibly as many as 35% have been misdiagnosed as suffering from epilepsy. This does not include the 18% of patients who declined the offer of a review or failed to attend, and our experience is that a significant number declined a review because they felt they did not have epilepsy. Some of these patients will almost certainly also have been inappropriately labelled. If one assumes that the results of this survey are representative of the situation in the country as a whole (and there is no reason to suppose the contrary), then the implications are disconcerting to say the least. This is all the more worrying when one takes into account the fact that the population sampled was a skewed, wealthy middle-aged rural population with a relatively low prevalence of epilepsy.
If these figures were replicated in a typical district with a population of 250000 we could expect to find that of 1750 patients 406 have been misdiagnosed with epilepsy (prevalence 0.7 per 1000). We have seen in this survey that in the 12 months prior to a new diagnosis being established, nine of the 49 misdiagnosed patients attended A&E and a further four required hospital admission, with one other patient being seen by a GP out of the normal surgery hours because of their 'epilepsy'. Extrapolating the figures observed in this study to a typical district (population size, 250 OOO), one could expect that 75 patients will attend A&E because of their seizures and 33 will require hospital admission. This suggests that patients who have been misdiagnosed are an inappropriate drain on services which are not meeting their needs. Furthermore, once a patient has been labelled as 'epileptic', clinicians frequently fail to explore their condition further and little will have been gained in a therapeutic sense from the A&E attendance or hospital admission. The fact that an EEG is almost never performed in A&E or during an acute admission is testament to this fact.
One further observation worthy of note concerns the AEDs that patients were on prior to the service being established. It is recognized that phenytoin and phenobarbitone no longer have a place as first-line treatment for epilepsy". Despite this, 11 of the 19 patients on AEDs were on this medication (58%). The cost of maintaining almost 9% of patients with a diagnosis of epilepsy on medication inappropriately has many more implications than the cost of the tablets.
In terms of an epidemiological study, the population sampled in this survey is relatively small. Despite this, we believe that the observations made are significant and if this survey has done nothing else, it has highlighted the fact that epilepsy is frequently misdiagnosed at a substantial cost to both the patient and the Health Service. Given the high standard of healthcare in other disease areas and the increasing burden placed on the Health Service, this situation is unacceptable. Apart from the clinical and social ramifications of misdiagnosis, the increasing trend for litigation places an added responsibility on the physician to establish an accurate diagnosis. The burden of care on the National Health Service in terms of hospital admissions, A&E attendances, etc. is also a worrying aspect. Although clinicians cannot be expected to obtain a correct diagnosis every time, it is suggested that with greater care and improved understanding of epilepsy and other seizure conditions, diagnostic guidelines and protocols can be established which minimize the risk of misdiagnosis.
